Dr. Martens plc DOCMF OTC

Dr. Martens plc (DOCMF) generated $196.3M in operating cash flow for fiscal year 2025. After capital expenditures of $18.7M, free cash flow was $177.6M.

Free cash flow margin was 22.5% of revenue. Cash conversion ratio was 43.62x, indicating earnings are backed by cash.

The company returned $9.5M in dividends to shareholders during the period.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (64/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (30/100) — Cash conversion ratio was 43.62x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 42/100 with 1/7 criteria passed.